Prof. Fennell’s clinical specialisation is in thoracic medical oncology and early clinical trials, with a particular interest in therapeutic targeting of the core apoptosis pathways. He is the Translational Research Coordinator and Chair of Medical Oncology of the EORTC lung Cancer Group, and member of both the NCRI lung cancer clinical studies and biomarker committees.
Prof. Fennel has numerous society affiliations including: CR-UK representative to the EORTC; EORTC Board Member; Board of Directors of the International Mesothelioma Interest Group, and; Member of the Cancer Research UK’s Biomarkers and Bioimaging Discovery Committee.
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!